As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

New 2026 program information covers self-pay pricing tiers, HSA/FSA eligibility, compounded semaglutide and tirzepatide ...

AI could streamline drug safety detection by identifying adverse events in EHR clinical notes, improving automation at Vanderbilt and UCSF.

AI Impact examines how AI is reshaping demand, exposing risk and forcing faster decisions across pricing, governance and ...

Healthcare organizations have been operating in survival mode. Protecting thin margins, managing workforce strain, and absorbing continuous disruption. These near-term pressures have been unavoidable ...

Biomedical data analysis has evolved rapidly from convolutional neural network-based systems toward transformer architectures and large-scale foundation ...

Both eligibility and access criteria for liver transplantation (LT) have continued to evolve as indications broaden; ...

TORONTO, ON / ACCESS Newswire / April 7, 2026 /Predictiv AI Inc. (CSE:PAI)(FWB:7IT) ("Predictiv AI" or the "Company") today announced the filing of a patent application covering its method for ...

Emergency Department, Torcuato de Alvear Psychiatric Emergency Hospital, Buenos Aires, Argentina. 2 Center for Interdisciplinary Forensic Research (CIDIF), National Academy of Sciences, Buenos Aires, ...

Quantitative results show that only a small fraction of possible pathways linking AI outputs to decision mechanisms are actively implemented. In many cases, the majority of these pathways remain ...

Artificial intelligence has already proven it can perform specific medical tasks, such as interpreting X-rays or flagging ...